Trials / Completed
CompletedNCT05081089
Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali
A Four-arm Trial Comparing Artemether-lumefantrine With or Without Single-dose Primaquine and Sulphadoxine-pyrimethamine/Amodiaquine With or Without Single-dose Tafenoquine to Reduce P. Falciparum Transmission in Mali
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- London School of Hygiene and Tropical Medicine · Academic / Other
- Sex
- All
- Age
- 10 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the gametocytocidal and transmission reducing activity of artemether-lumefantrine (AL) with and without a single dose of 0.25mg/kg primaquine (PQ) and sulfadoxine-pyrimethamine with amodiaquine (SPAQ) with and without single dose of 1.66mg/kg tafenoquine (TQ). Outcome measures will include infectivity to mosquitoes at 2, 5 and 7 days after treatment, gametocyte density throughout follow-up, and safety measures including haemoglobin density and the frequency of adverse events.
Detailed description
Full protocol available on request.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Artemether-lumefantrine | Tablets containing 20/80 mg artemether and 120/480 mg lumefantrine will be administered according to weight as per manufacturer guidelines. |
| DRUG | Primaquine Phosphate | The single dose of 0.25mg/kg PQ will be administered in an aqueous solution, according to a standard operating procedure (SOP) provided by the manufacturer. |
| DRUG | Sulphadoxine-pyrimethamine with amodiaquine | Sulfadoxine/pyrimethamine tablets contain 500mg sulfadoxine and 25mg pyrimethamine. Amodiaquine tablets contain 150mg amodiaquine (as hydrochloride). Tablets will be administered according to weight as per manufacturer guidelines. |
| DRUG | Tafenoquine | 100mg tafenoquine tablets are prepared into a 1mg/mL solution in water. Solution will be given according to weight as indicated per treatment arm in 5kg bands. |
Timeline
- Start date
- 2021-10-12
- Primary completion
- 2021-12-16
- Completion
- 2022-01-13
- First posted
- 2021-10-18
- Last updated
- 2022-01-18
Locations
1 site across 1 country: Mali
Source: ClinicalTrials.gov record NCT05081089. Inclusion in this directory is not an endorsement.